B

Boti

Acquired

Biotech company; acquired by Allergan

Boti is a biotech company, founded in 2015. It has raised $27.2M across 2 rounds, most recently a $15.5M Series C in January 2018.

Employees
1–10
Founded
2015
Business Model
B2B
Total Funding
$27.2M
Last Round
$15.5M Series CJan 2018
Rounds
2
Acquisition Date
Sep 2018

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 1 investor for this company. to use credits for reveals, or explore the API.

About

Bonti, Inc. was a Newport Beach, California-based clinical-stage biotechnology company founded in 2015 that developed EB-001, a fast-acting, short-duration botulinum neurotoxin of serotype E for cosmetic and therapeutic use, positioned as an alternative to longer-lasting neuromodulators like Botox. The company raised roughly $36 million in funding before Allergan plc acquired it in October 2018 for $195 million upfront, adding new neurotoxin programs to Allergan's medical aesthetics pipeline.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionSep 2018

2 more funding events

  • Series C20181 investor
  • Series B20171 investor

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Boti on Indexed.vc
<a href="https://indexed.vc/companies/boti"><img src="https://indexed.vc/api/badge/company/boti" alt="Boti on Indexed.vc" width="260" height="76" /></a>